AOAC OMA# 2011.14 (Final Action Review)-OMB

2011.14 (Oct. 2018) – MTE-03 Final Action Review FOR ERP USE ONLY DO NOT DISTRIBUTE

We thank Stefan de Boer and Ilse Voortman from FrieslandCampina LQS (Leeuwarden, The Netherlands) for the results processing and statistical analysis. We also thank Lawrence Paquette and Joseph Thompson (Abbott Nutrition), the Co- Study Directors of the Official Method 2015.06 multilaboratory study, for their help in harmonizing the study protocols for the ICP-AES and ICP-MS methods.

References

1. 21CFR107: Infant Formula, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPa rt=107 , accessed February 2018. 2. Stakeholder Panel on Infant Formula and Adult Nutritionals: Standard Method Performance Requirements http://stakeholder.aoac.org/SPIFAN/smpr.html , accessed February 2018. 3. Official Methods of Analysis (2016) 20 th Ed., AOAC INTERNATIONAL, Rockville, MD www.eoma.aoac.org , SMPR 2014.004 4. Poitevin, E. (2016) J AOAC Int. 99 , 42-52. 5. SPIFAN SLV Kit, http://stakeholder.aoac.org/SPIFAN/SPIFAN_SLV_Kit.pdf , available from Covance Laboratories, Greenfileld, IN. 6. National Institute of Standards and Technology Standard Reference Material 1849a https://www-s.nist.gov/srmors/view_detail.cfm?srm=1849a 7. Official Methods of Analysis (2016) 20 th Ed., AOAC INTERNATIONAL, Rockville, MD www.eoma.aoac.org , Appendix D.